AcelRx Pharmaceuticals, Inc. (TLPH)

Last Three Months

26-Jan-24 -- 25-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drug Manufacturers - Major

Drugs

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

19

0

5

+1

0

+2

0

+3

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Mar-24 8:57 PM View:	03-Mar-24 Payment of Exercise ($0.53K)	Dasu Badri N Chief Engineering Officer		AcelRx Pharmaceuticals, Inc. - TLPH	67% 18.77K to 31.41K	0	0	--	--	Show Txns Hide Txns

12-Mar-24 6:39 PM View:	12-Mar-24 Grant $9.00K	Angotti Vincent J. Chief Executive Officer Director		AcelRx Pharmaceuticals, Inc. - TLPH	68% 101.81K to 170.81K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 8:54 PM View:	03-Mar-24 Payment of Exercise ($0.73K)	Asadorian Raffi Chief Financial Officer		AcelRx Pharmaceuticals, Inc. - TLPH	71% 22.08K to 37.73K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:01 PM View:	15-Mar-24 Exercise (in-the money or at-the-money) $3.78M	Nantahala Capital Managemen... 10% Owner		AcelRx Pharmaceuticals, Inc. - TLPH	61% 1.24M to 1.99M	0	0	--	--	Show Txns Hide Txns

04-Mar-24 8:55 PM View:	03-Mar-24 Payment of Exercise ($0.58K)	Palmer Pamela P Chief Medical Officer		AcelRx Pharmaceuticals, Inc. - TLPH	60% 36.95K to 59.15K	0	0	--	--	Show Txns Hide Txns